Jpmorgan Chase & CO Medicinova Inc Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Medicinova Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 11,276 shares of MNOV stock, worth $22,664. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,276
Previous 5,376
109.75%
Holding current value
$22,664
Previous $7,000
228.57%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding MNOV
# of Institutions
31Shares Held
4.83MCall Options Held
9.4KPut Options Held
6K-
Essex Woodlands Management, Inc. The Woodlands, TX1.11MShares$2.22 Million0.67% of portfolio
-
Black Rock Inc. New York, NY695KShares$1.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA623KShares$1.25 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA506KShares$1.02 Million0.0% of portfolio
-
Citigroup Inc448KShares$900,3930.0% of portfolio
About MEDICINOVA INC
- Ticker MNOV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,046,200
- Market Cap $98.6M
- Description
- MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...